Publication | Closed Access

Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone

Mycophenolate MofetilHepatologyTriple TherapyLiver PhysiologyPharmacologyBiliary DisorderHepatotoxicityUrsodeoxycholic AcidLiver DiseaseLiver TransplantationMedicineDrug-induced Liver Injury